Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) EBT Margin (2016 - 2019)

Historic EBT Margin for Phio Pharmaceuticals (PHIO) over the last 8 years, with Q1 2019 value amounting to 10219.05%.

  • Phio Pharmaceuticals' EBT Margin fell 4842700.0% to 10219.05% in Q1 2019 from the same period last year, while for Dec 2019 it was 42795.24%, marking a year-over-year decrease of 374619000.0%. This contributed to the annual value of 42419.05% for FY2019, which is 370857100.0% down from last year.
  • Latest data reveals that Phio Pharmaceuticals reported EBT Margin of 10219.05% as of Q1 2019, which was down 4842700.0% from 2619.3% recorded in Q3 2018.
  • Phio Pharmaceuticals' EBT Margin's 5-year high stood at 2619.3% during Q3 2018, with a 5-year trough of 24577.78% in Q2 2016.
  • Over the past 5 years, Phio Pharmaceuticals' median EBT Margin value was 9976.92% (recorded in 2018), while the average stood at 11843.37%.
  • In the last 5 years, Phio Pharmaceuticals' EBT Margin plummeted by -136482400bps in 2016 and then plummeted by -4842700bps in 2019.
  • Over the past 5 years, Phio Pharmaceuticals' EBT Margin (Quarter) stood at 8661.76% in 2015, then crashed by -184bps to 24577.78% in 2016, then soared by 46bps to 13346.67% in 2017, then soared by 80bps to 2619.3% in 2018, then crashed by -290bps to 10219.05% in 2019.
  • Its EBT Margin stands at 10219.05% for Q1 2019, versus 2619.3% for Q3 2018 and 3277.59% for Q2 2018.